ALX Oncology Holdings Inc
(NAS:ALXO)
$
2.39
0.06 (2.58%)
Market Cap: 125.89 Mil
Enterprise Value: -21.07 Mil
PE Ratio: 0
PB Ratio: 0.79
GF Score: 28/100 ALX Oncology Holdings Inc (ALXO) Transcripts
- ALX Oncology Holdings Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- ALX Oncology Holdings Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- ALX Oncology Holdings Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- ALX Oncology Holdings Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- ALX Oncology Holdings Inc Discuss The Initial AML Data From ASPEN-05 - Conference Call TranscriptDec 13, 2022
- ALX Oncology Holdings Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- ALX Oncology Holdings Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- ALX Oncology Holdings Inc SITC 2021 Conference Call TranscriptNov 09, 2021
- ALX Oncology Holdings Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 08, 2021
- ALX Oncology Holdings Inc to Discuss New Data from ASPEN-01 and the Phase 1b Study of ALX148 Call TranscriptJul 06, 2021
- ALX Oncology Holdings Inc Annual Shareholders Meeting TranscriptJun 10, 2021
- ALX Oncology Holdings Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2021
- ALX Oncology Holdings Inc at UBS Global Healthcare Virtual Conference TranscriptMay 24, 2021
- ALX Oncology Holdings Inc at H C Wainwright Global Life Sciences Conference (Virtual) - Pre-Recorded Fireside Chat TranscriptMar 09, 2021
- ALX Oncology Holdings Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- ALX Oncology Holdings Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 19, 2020
- 1